Related Articles
Endometrial carcinoma in a breast cancer patient treated with tamoxifen
p27, cyclin E, and CDK2 expression in normal and cancerous endometrium
Differences in estrogen and progesterone receptor expression in endometrial polyps and atrophic endometrium of postmenopausal women with and without exposure to tamoxifen
Molecular mechanisms of tamoxifen-associated endometrial cancer (Review)
Differential effects of raloxifene and tamoxifen on the expression of estrogen receptors and antigen Ki-67 in human endometrial adenocarcinoma cell line